NASDAQ:IIVI - II-VI Stock Price, Forecast & News

II-VI trades on the NASDAQ under the ticker symbol "IIVI."

II-VI, Inc. (NASDAQ:IIVI) announced its quarterly earnings data on Monday, February, 10th. The scientific and technical instruments company reported $0.36 earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of $0.36. The scientific and technical instruments company earned $666.30 million during the quarter, compared to analyst estimates of $610.30 million. II-VI had a negative net margin of 4.18% and a negative return on equity of 4.44%. II-VI's quarterly revenue was up 94.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.71 earnings per share. View II-VI's Earnings History.

II-VI is scheduled to release their next quarterly earnings announcement on Wednesday, May 6th 2020. View Earnings Estimates for II-VI.

II-VI updated its third quarter earnings guidance on Monday, February, 10th. The company provided earnings per share guidance of $0.02-0.32 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.39. The company issued revenue guidance of $550-600 million, compared to the consensus revenue estimate of $616.17 million.

15 analysts have issued 12 month target prices for II-VI's shares. Their forecasts range from $30.00 to $53.00. On average, they anticipate II-VI's stock price to reach $41.31 in the next year. This suggests a possible upside of 11.3% from the stock's current price. View Analyst Price Targets for II-VI.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for II-VI in the last year. There are currently 5 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for II-VI.

Press coverage about IIVI stock has been trending somewhat positive on Friday, InfoTrie reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. II-VI earned a news impact score of 2.0 on InfoTrie's scale. They also gave news articles about the scientific and technical instruments company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for II-VI.

Some companies that are related to II-VI include Emerson Electric (EMR), Eaton (ETN), Roper Technologies (ROP), Rockwell Automation (ROK), AMETEK (AME), Generac (GNRC), Enphase Energy (ENPH), Acuity Brands (AYI), Regal Beloit (RBC), EnerSys (ENS), Brady (BRC), Franklin Electric (FELE), Vicor (VICR), Belden (BDC) and Encore Wire (WIRE).

Based on aggregate information from My MarketBeat watchlists, some companies that other II-VI investors own include NVIDIA (NVDA), Alibaba Group (BABA), Walt Disney (DIS), Lumentum (LITE), Verizon Communications (VZ), Netflix (NFLX), Tesla (TSLA), CVS Health (CVS), Advanced Micro Devices (AMD) and Editas Medicine (EDIT).

II-VI's stock is owned by many different of retail and institutional investors. Top institutional investors include State Street Corp (3.00%), Barrow Hanley Mewhinney & Strauss LLC (2.63%), Robecosam AG (1.89%), Robecosam AG (1.89%), Iridian Asset Management LLC CT (1.53%) and Franklin Resources Inc. (1.46%). Company insiders that own II-VI stock include Christopher Koeppen, David G Wagner, Francis J Kramer, Howard H Xia, Joseph J Corasanti, Marc Y E Pelaez, Mary Jane Raymond, Shaker Sadasivam and Vincent D Mattera Jr. View Institutional Ownership Trends for II-VI.

IIVI stock was sold by a variety of institutional investors in the last quarter, including Mason Street Advisors LLC, DNB Asset Management AS, State of New Jersey Common Pension Fund D, Principal Financial Group Inc., Victory Capital Management Inc., Victory Capital Management Inc., State Street Corp and Falcon Point Capital LLC. Company insiders that have sold II-VI company stock in the last year include Christopher Koeppen, David G Wagner, Francis J Kramer, Howard H Xia, Marc Y E Pelaez, Mary Jane Raymond and Vincent D Mattera Jr. View Insider Buying and Selling for II-VI.

IIVI stock was bought by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, Franklin Resources Inc., Mariner LLC, Barrow Hanley Mewhinney & Strauss LLC, Robecosam AG, Robecosam AG, Pinnacle Associates Ltd. and Snow Capital Management LP. Company insiders that have bought II-VI stock in the last two years include Joseph J Corasanti and Shaker Sadasivam. View Insider Buying and Selling for II-VI.

Shares of IIVI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IIVI stock can currently be purchased for approximately $37.11.

II-VI has a market capitalization of $3.38 billion and generates $1.36 billion in revenue each year. The scientific and technical instruments company earns $107.52 million in net income (profit) each year or $1.63 on an earnings per share basis. II-VI employs 12,487 workers across the globe.View Additional Information About II-VI.

The official website for II-VI is http://www.ii-vi.com/.

II-VI's mailing address is 375 SAXONBURG BOULEVARD, SAXONBURG PA, 16056. The scientific and technical instruments company can be reached via phone at 724-352-4455 or via email at [email protected]